Febrile Neutropenia Market Size: Expanding Demand and Future Prospects
The Febrile Neutropenia Market Size has been expanding due to the rising number of chemotherapy patients and increasing awareness of infection risks associated with low neutrophil counts. Market growth is strongly influenced by innovative treatments, especially granulocyte colony-stimulating factors (G-CSFs), and improved supportive care options. Hospitals and oncology centers continue to lead...
0 Kommentare 0 Anteile 15 Ansichten 0 Vorschau